Age distribution of patients with advanced non-melanoma skin cancer in the United States

Archives of Dermatological Research

Volumn 305, Issue 9, 2013, Pages 845-850

  Dacosta Byfield, Stacey ^a   Chen, Diana ^b   Yim, Yeun Mi ^b   Reyes, Carolina ^b  

^a OPTUM   (United States)

^b GENENTECH INC   (United States)

Author keywords

Incidence; Metastasis; Non melanoma skin cancer; Prevalence

Indexed keywords

ADOLESCENT; ADULT; ADVANCED CANCER; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; FEMALE; HEALTH INSURANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; PATIENT IDENTIFICATION; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; INFANT; INSURANCE BENEFITS; INSURANCE CLAIM REVIEW; MALE; MELANOMA; MIDDLE AGED; PREVALENCE; REGISTRIES; SKIN NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 84886722768     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1357-2     Document Type: Article

References (16)

1. Athas WF, Hunt WC, Key CR (2003) Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev 12:1105-1108
2. Bath-Hextall F, Leonardi-Bee J, Smith C, Meal A, Hubbard R (2007) Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study. Int J Cancer 121:2105-2108. doi: 10.1002/ijc.22952
3. Boi S, Cristofolini M, Micciolo R, Polla E, Dalla Palma P (2003) Epidemiology of skin tumors: data from the cutaneous cancer registry in Trentino, Italy. J Cutan Med Surg 7:300-305. doi: 10.1007/s10227-002-0135-0
4. Centers for Medicare & Medicaid Services (2011) New, Revised, and Invalid Diagnosis and Procedure Codes FINAL VERSION - Effective January 10, 2011. http://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/ summarytables.html. Accessed 16 April 2013
5. Cherpelis BS, Marcusen C, Lang PG (2002) Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 28:268-273
6. Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV (2005) Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol 53:320-328. doi: 10.1016/j.jaad.2005.03.043
7. Health insurance portability and accountability act of 1996. Public law 104-191, 104th Congress (1996). http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/ HIPAALaw.pdf
8. Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM, Chen GJ (2003) Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48:425-429. doi: 10.1067/mjd.2003.186
9. Katalinic A, Kunze U, Schafer T (2003) Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 149:1200-1206
10. Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069-1080. doi: 10.1111/j.1365-2133.2012.10830.x
11. Malone JP, Fedok FG, Belchis DA, Maloney ME (2000) Basal cell carcinoma metastatic to the parotid: report of a new case and review of the literature. Ear Nose Throat J 79(511-515):518-519
12. Marks R (1995) The epidemiology of non-melanoma skin cancer: who, why and what can we do about it. J Dermatol 22:853-857
13. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283-287. doi: 10.1001/archdermatol.2010. 19
14. Skin Cancer Foundation Squamous cell carcinoma (SCC). http://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma?gclid= CIrStfqxsbUCFfBDMgodaxAAXQ. Accessed 12 Feb 2013
15. Skin cancer foundation squamous cell carcinoma: causes and risk factors. http://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/ scc-causes-and-risk-factors. Accessed 12 Feb 2013
16. Thyagarajan V, Norman H, Alexander KA, Napalkov P, Enger C (2012) Risk of mortality, fatal infection, and fatal malignancy related to use of anti-tumor necrosis factor-alpha biologics by rheumatoid arthritis patients. Semin Arthritis Rheum 42:223-233. doi: 10.1016/j.semarthrit.2012.05.004